These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28549334)

  • 41. Inhibitors of Ras-SOS Interactions.
    Lu S; Jang H; Zhang J; Nussinov R
    ChemMedChem; 2016 Apr; 11(8):814-21. PubMed ID: 26630662
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pyrimidine Triazole Thioether Derivatives as Toll-Like Receptor 5 (TLR5)/Flagellin Complex Inhibitors.
    Yan L; Liang J; Yao C; Wu P; Zeng X; Cheng K; Yin H
    ChemMedChem; 2016 Apr; 11(8):822-6. PubMed ID: 26634412
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Focused library with a core structure extracted from natural products and modified: application to phosphatase inhibitors and several biochemical findings.
    Hirai G; Sodeoka M
    Acc Chem Res; 2015 May; 48(5):1464-73. PubMed ID: 25894598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fluorescence polarization for the evaluation of small-molecule inhibitors of PCAF BRD/Tat-AcK50 association.
    Hu P; Wang X; Zhang B; Zhang S; Wang Q; Wang Z
    ChemMedChem; 2014 May; 9(5):928-31. PubMed ID: 24474698
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Small molecules, peptides and natural products: getting a grip on 14-3-3 protein-protein modulation.
    Bartel M; Schäfer A; Stevers LM; Ottmann C
    Future Med Chem; 2014 May; 6(8):903-21. PubMed ID: 24962282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rational design of selective small-molecule inhibitors for β-catenin/B-cell lymphoma 9 protein-protein interactions.
    Hoggard LR; Zhang Y; Zhang M; Panic V; Wisniewski JA; Ji H
    J Am Chem Soc; 2015 Sep; 137(38):12249-60. PubMed ID: 26352795
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting the transmembrane domain 5 of latent membrane protein 1 using small molecule modulators.
    Zhang B; Wang Y; Lin C; Li H; Wang X; Peng Y; Mineev KS; Wilson AJ; Wang H; Wang X
    Eur J Med Chem; 2021 Mar; 214():113210. PubMed ID: 33550183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Small-molecule modulators for epigenetics targets.
    Knapp S; Weinmann H
    ChemMedChem; 2013 Nov; 8(11):1885-91. PubMed ID: 24127276
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GPCR structures in drug design, emerging opportunities with new structures.
    Tautermann CS
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4073-9. PubMed ID: 25086683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of small molecule sphingomyelin synthase inhibitors.
    Deng X; Lin F; Zhang Y; Li Y; Zhou L; Lou B; Li Y; Dong J; Ding T; Jiang X; Wang R; Ye D
    Eur J Med Chem; 2014 Feb; 73():1-7. PubMed ID: 24374347
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expanding chemogenomic space using chemoproteomics.
    Jones LH
    Bioorg Med Chem; 2019 Aug; 27(15):3451-3453. PubMed ID: 31221609
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and validation of cryptochrome inhibitors that modulate the molecular circadian clock.
    Chun SK; Jang J; Chung S; Yun H; Kim NJ; Jung JW; Son GH; Suh YG; Kim K
    ACS Chem Biol; 2014 Mar; 9(3):703-10. PubMed ID: 24387302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Strategies to search and design stabilizers of protein-protein interactions: a feasibility study.
    Block P; Weskamp N; Wolf A; Klebe G
    Proteins; 2007 Jul; 68(1):170-86. PubMed ID: 17393392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural Re-engineering of the α-Helix Mimetic JY-1-106 into Small Molecules: Disruption of the Mcl-1-Bak-BH3 Protein-Protein Interaction with 2,6-Di-Substituted Nicotinates.
    Drennen B; Scheenstra JA; Yap JL; Chen L; Lanning ME; Roth BM; Wilder PT; Fletcher S
    ChemMedChem; 2016 Apr; 11(8):827-33. PubMed ID: 26844930
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hitting a Moving Target: How Does an N-Methyl Group Impact Biological Activity?
    Koay YC; Richardson NL; Zaiter SS; Kho J; Nguyen SY; Tran DH; Lee KW; Buckton LK; McAlpine SR
    ChemMedChem; 2016 Apr; 11(8):881-92. PubMed ID: 26805515
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Small molecule modulators of protein-protein interactions: selected case studies.
    Aeluri M; Chamakuri S; Dasari B; Guduru SK; Jimmidi R; Jogula S; Arya P
    Chem Rev; 2014 May; 114(9):4640-94. PubMed ID: 24673632
    [No Abstract]   [Full Text] [Related]  

  • 57. Small-Molecule Allosteric Modulators of the Protein Kinase PDK1 from Structure-Based Docking.
    Rettenmaier TJ; Fan H; Karpiak J; Doak A; Sali A; Shoichet BK; Wells JA
    J Med Chem; 2015 Oct; 58(20):8285-8291. PubMed ID: 26443011
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel Small Molecule Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa) from Natural Product Anabaenopeptin.
    Halland N; Brönstrup M; Czech J; Czechtizky W; Evers A; Follmann M; Kohlmann M; Schiell M; Kurz M; Schreuder HA; Kallus C
    J Med Chem; 2015 Jun; 58(11):4839-44. PubMed ID: 25990761
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent developments of small molecules targeting RNA m
    Gu J; Xu J; You Q; Guo X
    Eur J Med Chem; 2020 Jun; 196():112325. PubMed ID: 32330741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure-based design of small-molecule protein-protein interaction modulators: the story so far.
    Falchi F; Caporuscio F; Recanatini M
    Future Med Chem; 2014 Mar; 6(3):343-57. PubMed ID: 24575969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.